Epithelial ovarian cancer | The ROC criteria | M-CSF | HE4 | CA 125 | M-CSF+ HE4 | M-CSF+ CA 125 | HE4 + CA 125 | M-CSF+ HE4 + CA 125 |
---|---|---|---|---|---|---|---|---|
stage I | AUC | 0.7676* | 0.7285* | 0.7653* | 0.8536* | 0.8702* | 0.8326* | 0.9069* |
SE | 0.0681 | 0.0708 | 0.0416 | 0.0496 | 0.0433 | 0.0538 | 0.0353 | |
95% C.I. | 0.604-0.871 | 0.590-0.867 | 0.692-0.794 | 0.756-0.951 | 0.785-0.955 | 0.728-0.938 | 0.838-0.976 | |
p AUC = 0.5 | <0.001 | 0.0013 | 0.0005 | <0.001 | <0.001 | <0.001 | <0.001 | |
stage II | AUC | 0.8662* | 0.7647* | 0.8653* | 0.9008* | 0.9113* | 0.9208* | 0.9443* |
SE | 0.0483 | 0.0562 | 0.0389 | 0.0387 | 0.0393 | 0.0314 | 0.0265 | |
95% C.I. | 0.772-0.961 | 0.654-0.876 | 0.814-0.968 | 0.825-0.977 | 0.834-0.988 | 0.859-0.983 | 0.892-0.966 | |
p AUC = 0.5 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
stage III | AUC | 0.9336* | 0.9257* | 0.9114* | 0.9624* | 0.9608* | 0.9764* | 0.9714* |
SE | 0.0317 | 0.0291 | 0.0428 | 0.0250 | 0.0302 | 0.0302 | 0.0222 | |
95% C.I. | 0.871-0.996 | 0.869-0.984 | 0.828-0.995 | 0.913-1.011 | 0.902-1.020 | 0.903-1.020 | 0.928-1.015 | |
p AUC = 0.5 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
stage IV | AUC | 0.9096* | 0.9125* | 0.9474* | 0.9872* | 0.9665* | 0.9422* | 0.9894* |
SE | 0.0414 | 0.0428 | 0.0260 | 0.0086 | 0.0214 | 0.0353 | 0.0083 | |
95% C.I. | 0.829-0.991 | 0.829-0.996 | 0.897-0.998 | 0.970-1.004 | 0.925-1.008 | 0.873-1.012 | 0.973-1.006 | |
p AUC = 0.5 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
Total group | AUC | 0.8562* | 0.8324* | 0.9277* | 0.9257* | 0.9271* | 0.9182* | 0.9529* |
SE | 0.0316 | 0.0321 | 0.0221 | 0.0212 | 0.0225 | 0.0223 | 0.0172 | |
95% C.I. | 0.794-0.918 | 0.769-0.895 | 0.884-0.972 | 0.884-0.967 | 0.883-0.971 | 0.874-0.963 | 0.919-0.967 | |
p AUC = 0.5 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
Serous epithelial | AUC | 0.9058* | 0.8722* | 0.9046* | 0.9491* | 0.9558* | 0.9390* | 0.9659* |
SE | 0.0306 | 0.0347 | 0.0301 | 0.0199 | 0.0199 | 0.0233 | 0.0160 | |
95% C.I. | 0.846-0.966 | 0.805-0.964 | 0.846-0.964 | 0.910-0.989 | 0.917-0.995 | 0.893-0.985 | 0.930-0.997 | |
p AUC = 0.5 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
Endome-trioid epithelial | AUC | 0.7983* | 0.7845* | 0.9129* | 0.8978* | 0.8926* | 0.8927* | 0.9374* |
SE | 0.0491 | 0.0467 | 0.0305 | 0.0331 | 0.0343 | 0.0330 | 0.0241 | |
95% C.I. | 0.702-0.894 | 0.694-0.876 | 0.854-0.973 | 0.833-0.963 | 0.825-0.960 | 0.828-0.958 | 0.890-0.985 | |
p AUC = 0.5 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |